I. Walter‐Sack

<i>CYP2C19</i> Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole

Magdalena Maria ten Hoevel, Jürgen Burhenne, I. Walter‐Sack et al. · The Journal of Clinical Pharmacology · 2008 · 204 citations

Medicine, Pharmacokinetics, Pharmacology +16

Elevated Plasma Concentrations of Homocysteine in Antiepileptic Drug Treatment

Markus Schwaninger, Peter A. Ringleb, Ralph Winter et al. · Epilepsia · 1999 · 170 citations · Full text

Medicine, Neurology, Pharmacology +14

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

Jens Rengelshausen, Christoph Göggelmann, Jürgen Burhenne et al. · British Journal of Clinical Pharmacology · 2003 · 146 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Opposite effects of short-term and long-term St John’s wort intake on voriconazole pharmacokinetics

Jens Rengelshausen, Maria Josefine Banfield, K. Riedel et al. · Clinical Pharmacology & Therapeutics · 2005 · 139 citations

Medicine, Pharmacokinetics, Pharmacology +17

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

Cornelia von Hagens, I. Walter‐Sack, Maren Goeckenjan et al. · Breast Cancer Research and Treatment · 2017 · 124 citations

Medicine, Oncology, Pharmacology +12